---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-008672"
form_type: "8-K"
ticker: "CNBX"
cik: "0001343009"
company_name: "CNBX Pharmaceuticals Inc."
filed_at: "2022-12-29T23:59:59+00:00"
generated_at: "2026-06-20T21:50:42.020559+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Director Shaul Yemal resigns from CNBX Pharmaceuticals board effective Dec 25, 2022

## Summary
- Shaul Yemal resigned as Director and Board Member on December 25, 2022.
- Resignation was not due to any dispute with the company.
- No replacement named; board vacancy remains.

## SEC filing metadata
- accession: 0001683168-22-008672
- form_type: 8-K
- ticker: CNBX
- cik: 0001343009
- company_name: CNBX Pharmaceuticals Inc.
- filed_at: 2022-12-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1343009/000168316822008672/0001683168-22-008672-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1343009/000168316822008672/cnbx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-008672
- JSON: https://secwatch.observer/filing/0001683168-22-008672.json
- Plain text: https://secwatch.observer/filing/0001683168-22-008672.txt

## Key facts
- Executive change
  Shaul Yemal resigned as Director and Board Member at CNBX Pharmaceuticals Inc..
  - Action: resigned
  - Role: Director and Board Member
  source text: On December 25th, 2022, Shaul Yemal resigned his position as Director and Board Member.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1343009/000168316822008672/0001683168-22-008672-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.